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age separation of all urinary amino acids to detect 
any excesses. Although the yield of newly diagnosed 
inborn errors by this screening program is small, 
those few cases detect~d are important because they 
may le;id to a specific diagnosis that permits a prog-
nosis, a recurrence risk for other family members, 
and counseling about the possibility of treatment or 
prenatal diagnosis for future pregnancies. 
Clearly, genetic screening programs are an im-
portant component of the primary care physician's 
efforts in preventive medicine. Participation in and 
support of these programs is therefore strongly 
urged. 
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The Virginia Sickle Cell Anemia Awareness 
Program (VaSCAP): Education, Screening, 
and Counseling 
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In 1968, a program of screening for sickle trait 
carriers was begun as part of the work of the Hema-
tology Division, Department of j'vtedicine, at the 
Medical College of Virginia. It was felt that sickle cell 
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anemia was more of a public health problem than 
was generally recognized, and in addition to institut-
ipg screening and education programs, data were col-
lected to document the rela tive neglect of the prob-
lem. 
A survey of the Cjty of Richmond was con-
ducted to ascertain the level of awareness among 
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black adults of sickle cell anemia, a severe chronic 
disease affecting one of every 500 black babies. The 
results' showed that only 3 of every IO black adults 
had ever heard of this disease, and of those who 
recognized it, few understood the nature of the ill-
ness. Additional background information was col-
lected which further showed the lack of professional 
and public understanding of the importance of sickle 
cell anemia as a public health problem. These data,2 •3 
which attracted widespread attention, showed that 
sickle cell anemia research received far less support 
than other much Jess common chronic illnesses. 
Public attention was also focused on sickle cell 
anemia by publicity concerning a new "test tube" test 
for sickling, and claims for therapeutic benefit from 
intravenous urea solutions. The heightened interest in 
sickle cell disease finally resulted in the Sickle Cell 
Anemia Prevention Act of 1972, which included a 
series of sickle cell research and treatment centers 
plus screening, education, and counseling clinics 
throughout the nation. At that time VaSCAP com-
peted successfully for a contract under the national 
program, and expanded from a small screening effort 
to a larger, well-staffed clinic which could extend its 
effects state-wide. 
Although the ability to detect healthy carriers of 
the recessive sickle trait had existed for years, no 
widespread screening and genetic counseling had 
taken place prior to these new programs. Another 
factor which made mass screening economically fea-
sible was the development of rapid, simple in-
struments for performing hemoglobin elec-
trophoresis. Electrophoresis has distinct advantages 
over the classical sickle cell "prep" or the.newer test 
tube tests since it can distinguish sickle trait from the 
homozygous state, sickle cell anemia, and can also 
detect numerous other hemoglobin variants. 
The purpose of screening for abnormal hemo-
globins is to give young people an opportunity, not 
previously available, to know in advance of child-
bearing whether they run the risk of having children 
with sickle cell anemia. The frequency of sickle tr<1i t is 
about 8% of the black population, or I in every 12 
blacks. The chance, then, that both potential parents 
in a couple are trait carriers is I in 144; thus slightly 
less than I% of black couples are composed of two 
trait carriers and are at risk for bearing children with 
sickle cell anemia . The chance is I in 4 with each 
pregnancy that a child will be born with this incurable 
illness. 
Screening should not be performed without ade-
quate prior education. To implement this principle, 
VaSCAP has developed a number of audiovisual 
programs and written materials suitable for a wide 
variety of audiences. Included in these are the Sickle 
Cell Anemia Fact Book,4 a booklet for teachers, 
nurses, and other professionals, and Our Sickle Cell 
Story Fact Book,5 for elementary and middle school 
students. These, as well as brochures, posters, and 
fact sheets are distributed through the Virginia State 
Department of Health, to many areas of Virginia and 
throughout the nation. Since its inception, VaSCAP 
has provided educational sessions to over 200,000 
individuals in groups of various sizes. It has also 
reached many more through programs, spot an-
nouncements, and structured educational models for 
specific target groups with the result that screening 
for hemoglobin genes has become an acceptable pro-
cedure among the general population. At present 
over 42,000 persons have been screened by hemoglo-
bin electrophoresis and 3,951 have been found to 
have hemoglobin variants. 
The ultimate result of education and screening is 
counseling those found to have sickle or other mutant 
hemoglobin genes. Counseling is aimed at educating 
the individual so that he or she can know the nature 
of the sickle gene, understand what sickle cell anemia 
is, understand the probabilities of transmitting the 
genes, and then be able to make informed decisions 
about childbearing.There is a set of slides available 
which has been developed by the VaSCAP staff. 
These explain the probabilities of inheritance for each 
specific hemoglobin variant. Individuals newly diag-
nosed with sickle cell anemia or one of its variants 
have been referred to a family physician or to the 
Hematology Clinic at MCV. 
Approximately 8% of Virginia blacks have been 
found to have sickle cell trait, and 2% carry hemoglo-
bin C trait. About 0.3% have the gene for hereditary 
persistence of fetal hemoglobin (HPFH), which is a 
gene mutation not associated with any disease. In 
addition, a large number of less common mutant 
hemoglobin genes have been recognized. 
Though the alkaline electrophoresis test is the 
primary method used for the detection of hemoglobin 
genes, there are other methods which may be re-
quired in order to provide more conclusive results . 
The laboratory of the VaSCAP clinic provides both 
alkaline and acid or citrate agar electrophoresis. A2 
mini-columns for hemoglobin A2 quantitations are 
very useful in detecting the Beta thalassemias; fetal 
hemoglobin staining aids in determining the presence 
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of HPFH . Family studies are necessary in certain 
cases and the clinic has screened as many as four 
generations in some families. 
All of the services have been provided without 
charge to the public or physicians for whom diagnos-
tic testing has been performed . The emphasis has 
been on testing persons in or approaching the child-
bearing age. 
Education programs have been carried out in 
most high schools and colleges in central Virginia and 
the Tidewater area. Church groups and community 
organizations regularly request programs, many of 
which are provided in evenings or on weekends . An 
important part of the educational effort has been to 
provide workshops to train public health nurses in 
genetic counseling relating to hemoglobinopathies. 
State legislstion has provided funds for nurses to be 
designated as genetic counselors in all of the Health 
Department clinics in the State. VaSCAP has also 
worked closely with local health departments in pro-
viding consultations concerning diagnosis and coun-
seling of individuals with unusual hemoglobin vari-
ants . 
The number of individuals served by the VaS-
CAP clinic is a tangible measure of its performance, 
but it does not reflect all of the benefits to the public 
and health professionals. The tragic lack of public 
awareness of the importance of sickle cell anemia that 
characterized the beginnings of this program has dis-
appeared. For health professionals, especially at 
MCV, the subject of hemoglobinopathies has been 
emphasized repeatedly, and the level of interest and 
understanding of the disease and its variants have 
risen considerably. Of particular significance are the 
improved diagnostic facilities provided by VaSCAP 
clinics which have made it possible to stress the more 
rigorous modern standard of diagnosis for hemoglo-
bin disorders .6 Perhaps most important to the field of 
genetics generally has been the extensive practical 
experience gained by the first mass screening efforts 
for a heritable disease. The ease with which recessive 
hemoglobin genes are detected made it the first such 
program to be implemented; as additional gene tests 
are developed, other genetic diseases will be the tar-
gets of similar programs. 
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